@MDPIOpenAccess This study suggests that repeated exposures to SARS-CoV-2 via infection and mRNA vaccination shape the immune response against the virus through imprinting, transient hybrid immunity, and immune damping. https://t.co/fGE93sBh8U
@EricTopol My apologies for the intromission but I would like to share with you our study on the decline of anti-RBD antibodies after BNT162b2. 6-month follow up data in process. Best regards. https://t.co/eLxSmXMKdt
In a second vote, FDA advisers recommend a booster dose of Pfizer's vaccine for people 65 and older and those at high risk of severe Covid
https://t.co/KkmHSgooW1
Anti-spike antibodies decreased 3 mo. after the 2nd dose of BNT162b2 in healthy adults; only 41% maintained levels corresponding to an ID50 > 1:250. Booster doses of BNT162b2 might be required. #COVID19#COVID19Vaccine
https://t.co/eLxSmXMKdt
Different #COVID19 treatments might have different efficacies at different stages of illness in different manifestations of disease, and no 1 treatment is likely to 'cure' COVID19 https://t.co/LEF9ijN6jb
2019 Novel #Coronavirus (2019-nCoV) Update. Anthony Fauci discusses the latest developments with JAMA Editor Howard Bauchner. #CoronavirusOutbreak#JAMALive https://t.co/wbzAlCzqVq